The first World AIDS Day is noted as a global health day on December 1, 1988.

NHF hosts its 66th annual Bleeding Disorders Conference.

NHF hosts a Steps for Success event titled, "Hemophilia Pharmacy Management: Steps for Success With Managed Care and Specialty Pharmacy" that was designed to meet the educational needs of specialty pharmacists, home health pharmacists, health plan pharmacists, managed Medicaid pharmacists, medical directors, and other health care professionals with an interest in the management of patients with hemophilia.

On January 17, 1983, NHF issued a statement calling on manufacturers of blood products to refuse blood donations by Gay men.

The CDC teams up with Cooley's Anemia Foundation to create a blood safety program modeled after the successful program already in place for hemophilia patients.

A 10-year study on joint damage run by NHF medical trustee Henry H. Jordan concludes. A few years later, Henry would publish a monograph on his findings involving 56 hemophilia patients.

In 1946, Dr. Henry Jordan, a surgeon and medical trustee of NHF, began a program for the orthopedic treatment of hemophilia patients. The study was funded and conducted in cooperation with NHF, and was run out of Lenox Hill Hospital in New York City. The study included 110 patients and ran through 1956.

Dr. Henry Jordan, a trustee of the medical advisory council of the National Hemophilia Foundation, publishes a well-received book on treatments for hemophilic arthropathy (joint damage). The research cases featured in the book were funded by NHF.

Lee, the son of NHF's founders, was born in 1941* but was not diagnosed with hemophilia until he experienced an abdominal bleed 14 months later. *NOTE: Some public records indicate Lee's birth year as "about 1942" despite NHF's official record memos having his birth year listed as 1941.

Dr. Henry H. Jordan, an orthopedic surgeon who was a pioneer in the orthopedic treatment of hemophiliacs passed his way. Throughout his career, much of his work was funded by NHF.